Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines to meet the major unmet medical needs of patients on a global basis.

Find out more.

News

  • October 14, 2014

    Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda

  • October 13, 2014

    Clinical Data for AMITIZA® Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting

  • October 9, 2014

    Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA

  • October 7, 2014

    Sucampo Announces Departure of Chief Financial Officer